Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE

Anca D Askanase,Joan T Merrill,Qing Zuraw,Wei Tang,Betsy Brotherton,Robert Gordon

doi:10.1136/lupus-2022-000875

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE

Anca D Askanase, Joan T Merrill + Show 4 more

Open Access

https://doi.org/10.1136/lupus-2022-000875

Copy DOI

Journal: Lupus Science & Medicine	Publication Date: Apr 1, 2023
Citations: 1	License type: open-access

Affiliation: Columbia University Irving Medical Center, Oklahoma Medical Research Foundation, Janssen (United States), Westchester Medical Center, IQVIA (United States)

#Patient-reported Outcome #British Isles Lupus Assessment Group + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveThe Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) system is a novel and simple SLE disease activity instrument, consisting of a tandem clinician-reported (ClinRO) and patient-reported...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Lupus Science & Medicine

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.